Elevance Health Files 8-K on Shareholder Votes

Ticker: ELV · Form: 8-K · Filed: 2024-05-15T00:00:00.000Z

Sentiment: neutral

Topics: shareholder-vote, corporate-governance, sec-filing

Related Tickers: ELV

TL;DR

Elevance Health shareholders voted on company matters May 15th. Details to follow.

AI Summary

Elevance Health, Inc. filed an 8-K on May 15, 2024, to report on matters submitted to a vote of its security holders. The filing indicates that the company held a meeting where shareholders voted on various corporate matters. Specific details of the votes, such as resolutions passed or failed and the outcomes, are not detailed in this initial report but are typically provided in subsequent filings or exhibits.

Why It Matters

This filing informs investors about key decisions made by shareholders, which can impact the company's governance and future strategic direction.

Risk Assessment

Risk Level: low — This is a routine filing reporting on shareholder votes, not indicating any immediate financial distress or significant operational changes.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted for a vote by Elevance Health's security holders?

The 8-K filing states that matters were submitted to a vote of security holders, but the specific resolutions are not detailed within this report and would typically be found in exhibits or subsequent filings.

When was the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is May 15, 2024.

What is Elevance Health's principal executive office address?

The principal executive offices are located at 220 Virginia Ave, Indianapolis, IN 46204.

What was Elevance Health's former company name?

Elevance Health was formerly known as Anthem, Inc., WELLPOINT, INC, and WELLPOINT INC.

Under which jurisdiction was Elevance Health incorporated?

Elevance Health was incorporated in Indiana.

From the Filing

0001156039-24-000069.txt : 20240515 0001156039-24-000069.hdr.sgml : 20240515 20240515171430 ACCESSION NUMBER: 0001156039-24-000069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 24952526 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 axsubmissionofmatterstoavo.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 15, 2024 Date of Report (Date of earliest event reported) ___________________________________ Elevance Health, Inc. (Exact name of registrant as specified in its charter) ___________________________________ Indiana (State or other jurisdiction of incorporation or organization) 001-16751 (Commission File Number) 35-2145715 (I.R.S. Employer Identification Number) 220 Virginia Ave Indianapolis, IN 46204 (Address of principal executive offices and zip code) (833) 401-1577 (Registrant's telephone number, including area code) ________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark whether the registrant is an emerging growth company as defined Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter). Emerging growth company    ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07 - Submission of Matters to a Vote of Security Holders On May 15, 2024, Elevance Health, Inc. (the " Company ") held its Annual Meeting of Shareholders. The shareholders of the Company voted as follows on the matters set forth below. 1. Election of Directors . The following nominees for director were elected to serve three-year terms to expire at the Company’s annual meeting of shareholders in 2027 based on the following votes: Nominee For Against Abstain Broker Non-Votes Lewis Hay, III 191,694,052 4,384,617 196,126 12,814,049 Antonio F. Neri 189,550,610 6,514,535 209,650 12,814,049 Ramiro G. Peru 183,447,281 12,625,588 201,926 12,814,049 2. Advisory vote on the C

View on Read The Filing